Anxiety help for teens with PKU
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a brief therapy program designed to help teens with PKU manage anxiety or depression symptoms. It aims to see if this approach can prevent or treat these issues in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 10 to 17 years old and at least one parent or guardian is willing to take part
- You have a confirmed diagnosis of PKU from newborn screening and started treatment in your first 30 days of life
- You are interested in learning skills to help with anxiety or depression
- You live in Missouri, Kansas, or Illinois
- You do not have a significant intellectual disability or major language difficulties that would make therapy hard
- You are not planning to start another therapy or change your current medications during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
This study tests whether a specific mix of large neutral amino acids (LNAAs) can help adults with classical PKU by lowering phenylalanine levels in the brain. It includes an MRI and PET scan to see how the treatment affects brain activity.
This trial tests a one-time gene therapy called NGGT002 for adults with classic PKU who cannot take or do not respond well to current treatments. The goal is to see if it can safely lower blood phenylalanine levels.
This study looks at how nutrition affects risk factors in adults with PKU (a condition that requires a special diet to control certain blood chemicals). If you can manage your diet independently and agree to follow the study diet plan, this may help researchers find better nutritional approaches.
This study looks at how taking Palynziq affects your nutrition and health in people with phenylketonuria (PKU). You might benefit by getting careful monitoring while researchers learn how the medicine changes diet-related measurements.
This study looks at how educational, social support, and nutrition help affect pregnancy outcomes and quality of life in women with PKU. It may help you better manage PKU-related needs before and during pregnancy.
Hear when a new Phenylketonurias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.